Surgery Partners, Inc. SGRY R2K
Healthcare · Medical Care Facilities · United States
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
READ MORE ›$13.36
-43.41% 1Y
Market & Price
Market Cap
$1.75B
Current Price
$13.36
High / Low (52W)
$23.84 / $11.49
Beta
1.99
Valuation
Stock P/E
-
Industry PE
23.65
Forward P/E
20.83
PEG Ratio
-
Book Value
$13.03
Price to Book
1.03
P/S
0.52
EV/EBITDA
11.32
Dividend Yield
-
Profitability & Returns
ROCE
5.19%
ROE
2.75%
ROA
3.70%
Profit Margin
-2.28%
Op Margin
10.37%
EPS (Latest Qtr)
$-0.28
EPS (TTM)
$-0.59
Balance Sheet & Liquidity
Debt/Equity
1.16
Quick Ratio
1.35
Current Ratio
1.86
Debt
$4.04B
Total Assets
$8.12B
Current Assets
$1.15B
Working Capital
$535.20M
Ownership
Promoter Holding
1.70%
Chg in Prom Hold
-
FII / Inst Holding
123.32%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$7.38B
Total Revenue (TTM)
$3.34B
EBITDA
$652.20M
Free Cash Flow
$199.06M
Operating Cash Flow
$280.00M
Shares Outstanding
130.79M
Gross Margin
22.83%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
9.22%
Profit 5Y
-14.22%
Revenue (YoY)
4.50%
Earnings (YoY)
-
PROS
- Generates positive free cash flow.
CONS
- Earnings shrank at -14.2% CAGR over 5 years.
- Trading 44.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SGRY Surgery Partners, Inc. R2K | 13.36 | - | $1.75B | - | 5.19% | 2.75% | 9.22% | -14.22% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 224.14M | 232.83M | 239.60M | 263.32M | 267.07M | 289.68M | 282.68M | 306.00M | 286.18M | 288.35M | 460.35M | 417.37M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 776.00M | 826.20M | 821.50M | 885.00M | 810.90M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 614.10M | 630.60M | 626.20M | 672.80M | 650.70M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 161.90M | 195.60M | 195.30M | 212.20M | 160.20M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 72.30M | 74.30M | 60.20M | 87.40M | 76.10M |
| Operating Income | 38.35M | 41.00M | 44.27M | - | 34.28M | 50.95M | 42.85M | - | 41.72M | 37.74M | - | 41.20M | 43.50M | 45.00M | - | 49.60M | 55.50M | 59.00M | - | 23.50M | 44.70M | 18.50M | 64.30M | 59.50M | 63.60M | 100.40M | 76.50M | 74.10M | 46.40M | 97.60M | 82.60M | 76.00M | 84.80M | - | - | 89.60M | 121.30M | 135.10M | 124.80M | 84.10M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 98.20M | 152.00M | 145.20M | 170.10M | 104.30M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 62.20M | 67.90M | 74.90M | 67.60M | 69.10M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -300.00K | 43.80M | 30.80M | 42.60M | -3.30M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | -1.10M | 5.50M | 13.60M | -1.20M |
| Net Income | -6.76M | -5.43M | -3.12M | 16.74M | -7.19M | 2.12M | -2.34M | 16.86M | -2.75M | -4.47M | -32.18M | -17.50M | -19.50M | -21.00M | -147.70M | -20.10M | -19.80M | -15.70M | -19.20M | -27.50M | -32.50M | -61.60M | -21.00M | -26.90M | -22.90M | 12.20M | -18.40M | -25.00M | -24.90M | 18.90M | -4.90M | -12.40M | -15.50M | - | - | -37.70M | -2.50M | -22.70M | -15.00M | -35.90M |
| Diluted EPS | -0.21 | -0.17 | -0.10 | 0.35 | -0.15 | 0.04 | -0.05 | 0.35 | -0.06 | -0.09 | -0.83 | -0.53 | -0.57 | -0.61 | -3.25 | -0.60 | -0.59 | -0.51 | -0.59 | -0.76 | -0.86 | -1.46 | -0.57 | -0.39 | -0.28 | 0.14 | -0.21 | -0.28 | -0.20 | 0.15 | -0.04 | -0.10 | -0.12 | - | - | -0.30 | -0.02 | -0.18 | -0.12 | -0.28 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 284.60M | 403.29M | 959.89M | 1.15B | - | - | - | - | 2.54B | 2.74B | 3.11B | 3.31B |
| Cost of Revenue | - | - | - | - | - | - | - | - | 1.96B | 2.10B | 2.37B | 2.54B |
| Gross Profit | - | - | - | - | - | - | - | - | 574.90M | 647.50M | 745.60M | 765.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | 217.00M | 239.00M | 291.30M | 294.20M |
| Operating Income | 58.23M | 50.81M | 144.75M | 196.48M | 77.80M | 235.90M | 183.00M | - | 357.90M | 408.50M | 454.30M | 470.80M |
| EBITDA | - | - | - | - | - | - | - | - | 460.00M | 446.10M | 501.40M | 565.50M |
| Interest Expense | - | - | - | - | - | - | - | - | 234.90M | 193.00M | 201.70M | 272.60M |
| Pretax Income | - | - | - | - | - | - | - | - | 110.30M | 135.00M | 147.10M | 116.90M |
| Tax Provision | - | - | - | - | - | - | - | - | 23.30M | -300.00K | 134.60M | 18.00M |
| Net Income | -9.06M | -65.90M | 1.43M | 9.45M | -205.70M | -74.80M | -116.10M | - | -54.60M | -11.90M | -168.10M | -77.90M |
| Diluted EPS | -0.28 | -2.04 | 0.04 | 0.20 | -4.96 | -2.29 | -3.19 | - | -0.59 | -0.09 | -1.33 | -0.61 |
Compounded Sales Growth
| 5 Years: | 9.22% |
| 1 Year: | 4.50% |
Compounded Profit Growth
| 5 Years: | -14.22% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -43.41% |
| 6 Months: | -20.90% |
| 3 Months: | -13.81% |
| 1 Month: | -3.68% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Aug 2017 | Sep 2017 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.86B | 2.10B | 2.30B | - | - | 4.62B | 4.68B | 5.02B | 5.41B | - | 6.68B | 6.88B | 7.89B | 8.12B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | 921.00M | 895.00M | 1.12B | 1.15B |
| Cash & Equivalents | 5.23M | 13.03M | 74.92M | 57.93M | 69.70M | 214.21M | - | 174.91M | 184.30M | 92.70M | 317.90M | - | 282.90M | 195.90M | 269.50M | 239.90M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | 71.40M | 75.20M | 88.40M | 96.60M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | 456.30M | 496.40M | 579.10M | 602.20M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | 3.40B | 3.51B | 4.25B | 4.59B |
| Current Liabilities | - | - | 141.39M | 181.29M | 186.72M | - | - | 303.00M | 349.30M | 398.10M | 556.80M | - | 493.40M | 523.00M | 624.40M | 615.50M |
| Long Term Debt | - | - | - | 1.29B | 1.47B | - | - | 2.19B | 2.33B | 2.60B | 2.88B | - | 2.56B | 2.70B | 3.27B | 3.60B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | 2.93B | 3.06B | 3.70B | 4.02B |
| Total Equity | - | - | -264.08M | -4.03M | 9.68M | - | 1.41B | 654.73M | 404.60M | 296.80M | 115.60M | - | 2.00B | 1.99B | 1.79B | 1.71B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | 125.96M | 126.59M | 127.11M | 129.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 49.08M | 21.95M | 84.48M | 125.24M | 144.60M | 129.50M | 246.90M | - | 158.80M | 293.80M | 300.10M | 274.30M |
| Investing Cash Flow | -3.62M | -271.02M | -134.84M | -184.75M | -128.90M | -85.20M | -88.40M | - | -307.90M | -225.60M | -488.50M | -246.60M |
| Financing Cash Flow | -37.66M | 310.96M | 33.37M | 71.28M | -6.30M | -135.90M | 66.70M | - | 42.10M | -155.20M | 262.00M | -57.30M |
| Capital Expenditure | -4.15M | -7.74M | -33.44M | -39.11M | -39.80M | -73.60M | -42.90M | - | -80.60M | -88.80M | -90.40M | -78.70M |
| Free Cash Flow | 44.93M | 14.21M | 51.04M | 86.13M | 104.80M | 55.90M | 204.00M | - | 78.20M | 205.00M | 209.70M | 195.60M |
| Net Change in Cash | - | - | - | - | - | - | - | - | -107.00M | -87.00M | 73.60M | -29.60M |
| Share Buybacks | 0 | 3.14M | 0 | 0 | 2.00M | 0 | 0 | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 22.6% | 23.6% | 23.9% | 23.1% |
| Operating Margin % | 20.5% | 12.6% | 15.1% | 17.2% | - | - | - | - | 14.1% | 14.9% | 14.6% | 14.2% |
| Net Margin % | -3.2% | -16.3% | 0.1% | 0.8% | - | - | - | - | -2.2% | -0.4% | -5.4% | -2.4% |
| ROE % | - | 25.0% | -35.5% | 97.7% | -50.8% | -25.2% | -100.4% | - | -2.7% | -0.6% | -9.4% | -4.5% |
| ROCE % | - | 3.0% | 7.5% | 9.3% | 1.8% | 5.1% | 3.8% | - | 5.8% | 6.4% | 6.3% | 6.3% |
Shareholding Pattern
Insiders
1.70%
Institutions
123.32%
Public Float
125.45%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Bain Capital Investors Llc | 38.19% | 49.95M | $667.29M |
| 2 | Janus Henderson Group PLC | 10.35% | 13.54M | $180.90M |
| 3 | Pentwater Capital Management Lp | 9.68% | 12.65M | $169.07M |
| 4 | King Street Capital Management, LP | 7.82% | 10.23M | $136.67M |
| 5 | UBS Group AG | 7.79% | 10.19M | $136.16M |
| 6 | Blackrock Inc. | 4.33% | 5.66M | $75.63M |
| 7 | Dimensional Fund Advisors LP | 4.05% | 5.30M | $70.76M |
| 8 | ClearBridge Investments, LLC | 3.15% | 4.12M | $55.02M |
| 9 | Vanguard Portfolio Management LLC | 2.77% | 3.63M | $48.48M |
| 10 | Vanguard Capital Management LLC | 2.62% | 3.43M | $45.84M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SGRY
No recent headlines available.